At a glance
ClinicalIndex Comparison RecordN/AActive· 79 enrolled
Drug / intervention
GORE® TAG® Thoracic Branch Endoprosthesis +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 0/1
In Brief
A clinical study evaluating GORE® TAG® Thoracic Branch Endoprosthesis and Revascularization Procedure for Aortic Aneurysm, Thoracic and Aorta, Lesion. Active but no longer recruiting, targeting 79 participants across 39 sites in 2 countries.
Detailed Summary
The objective of this study is to determine whether the GORE® TAG® Thoracic Branch Endoprosthesis is safe and effective in treating lesions of the aortic arch and descending thoracic aorta.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAortic Aneurysm, Thoracic, Aorta, Lesion
CountriesJapan, United States
Collaborators--
Timeline
N/AActive
201720182019202020212022202320242025202620272028
First PostedMay 2016
Enrollment StartAug 2016
Primary CompletionMar 2024
TodayJul 2026
Study CompletionMar 2028
First PostedMay 19, 2016
Enrollment StartAug 1, 2016
Primary CompletionMar 1, 2024
Study CompletionMar 1, 2028
TodayJul 2, 2026
Enrollment to primary: 7.6 yearsPosted 10.1 years ago
Interventions
GORE® TAG® Thoracic Branch Endoprosthesisdevice
Endovascular repair with the TBE Device
Revascularization Procedureprocedure
Revascularization procedure of the great vessel